DJIA 17,055.87 -116.81 -0.68%
NASDAQ 4,508.69 -19.00 -0.42%
S&P 500 1,982.77 -11.52 -0.58%
market minute promo

Vertex Pharmaceuticals (NASDAQ: VRTX)

104.84 0.13 (0.12%)

REAL-TIME: Last trade at

Extended Hours: $104.84 $0.00 (0.00%)
Quote as of (NASDAQ)



company name or ticker

Recent Quotes

VRTX $104.84 0.12%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $104.28
Previous Close $104.71
Daily Range $102.78 - $105.72
52-Week Range $58.06 - $105.72
Market Cap $25.0B
P/E Ratio -52.62
Dividend (Yield) $0.00 (0.0%)
Volume 2,406,350
Average Daily Volume 1,369,593
Current FY EPS -$2.81

Sector

Healthcare

Industry

Drugs

Vertex Pharmaceuticals (VRTX) Description

The Company is in the business of discovering, developing and commercializing small molecule drugs for the treatment of serious diseases. Website: http://www.vrtx.com/

News & Commentary

Has Gilead Sciences, Inc.'s Star Drug Already Peaked?

Prescriptions of Gilead Sciences' hepatitis C drug Sovaldi peaked, but sales will pick up after the new combination product is approved.

These 3 Biotech Stocks Just Hit New Highs

3 Stocks Pushing The Drugs Industry Higher

Vertex Pharmaceuticals (VRTX) Jumps: Stock Rises 6.6% - Tale of the Tape

Midday Gainers From September 19 - Alibaba Group Holding Ltd, Concur Technologies, Inc. And More

Nasdaq 100 Movers: MU, AMZN

Nasdaq 100 Movers: VRTX, YHOO

Uncertainty Prevails For Vertex

3 Stocks Underperforming Today In The Health Care Sector

Benzinga's Top Upgrades

Goldman Sachs Upgrades Vertex Pharmaceuticals To Buy

See More VRTX News...

VRTX's Top Competitors

VRTX $104.84 (0.12%)
Current stock: VRTX
AMGN $140.68 (-1.06%)
Current stock: AMGN
GILD $105.39 (-0.08%)
Current stock: GILD
BIIB $332.24 (0.75%)
Current stock: BIIB